AngioDynamics
ANGO
163 hedge funds and large institutions have $546M invested in AngioDynamics in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 13 closing their positions.
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
60% more call options, than puts
Call options by funds: $308K | Put options by funds: $193K
23% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 47
8% more funds holding
Funds holding: 151 → 163 (+12)
4% more capital invested
Capital invested by funds: $526M → $546M (+$19.6M)
0.69% more ownership
Funds ownership: 84.03% → 84.73% (+0.69%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$68.2M |
| 2 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
+$8.88M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$5.77M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.32M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
RGM Capital
Naples,
Florida
|
-$22.7M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$5.65M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$3.21M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$3.04M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.84M |
ANGO Hedge Fund Activity: Q1 2017 in Review
163 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2017, worth a combined $546M — up 3.7% from $526M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ANGO positions and 13 closed out — a net gain of 17 holders — while 58 added to existing stakes and 47 trimmed.
The largest buyer was BlackRock, adding an estimated $68.2M. The largest seller was RGM Capital, cutting an estimated $22.7M.
- 163 institutional investors held AngioDynamics (ANGO) as of Q1 2017, up from 151 in Q4 2016.
- Funds reported $546M of AngioDynamics stock for Q1 2017, up 3.7% quarter-over-quarter.
- 30 funds opened new AngioDynamics positions in Q1 2017 and 13 closed out, a net change of +17 holders.
- The largest AngioDynamics buyer in Q1 2017 was BlackRock, an estimated $68.2M added.
- The largest AngioDynamics seller in Q1 2017 was RGM Capital, an estimated $22.7M sold.
Based on aggregated 13F filings for Q1 2017.